{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:28:11Z","timestamp":1787772491053,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"\n Purpose:<\/jats:title>\n To study the risk factors of mucormycosis and analyze their association among nasal and orbital mucormycosis in Coronavirus disease 2019 (COVID-19) infection.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n All patients diagnosed of rhino-orbito-cerebral mucormycosis (ROCM) with previous COVID-19 infection were included in the study. The details such as age, sex, presence of co-morbidities, and serum ferritin levels were collected. ROCM patients were classified into two groups, nasal mucormycosis (stage 1 and 2 of ROCM) and orbital mucormycosis (stage 3 and 4 of ROCM), and data were collected. Duration of COVID-19 symptoms, the time interval between COVID-19 infection and onset of ROCM symptoms, computed tomography severity score (CTSS) and usage of steroids were collected accordingly. The collected data were compared between nasal group and orbital group.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Among 52 patients, 15 patients had nasal and 37 patients had orbital mucormycosis. Forty-one patients were more than 40 years, 43 patients were males. Seven out of ten risk factors were found to be significant on comparing nasal and orbital group. Patients of age more than 40 years (\n P<\/jats:italic>\n = 0.034), elderly diabetics (\n P<\/jats:italic>\n = 0.014), poor control of diabetes (\n P<\/jats:italic>\n = 0.003), high serum ferritin levels (\n P<\/jats:italic>\n = 0.043), duration between COVID-19 and mucormycosis of more than 20 days (\n P<\/jats:italic>\n = 0.038), CTSS of more than 9\/25 (\n P<\/jats:italic>\n = 0.020), and steroid usage during COVID-19 infection (\n P<\/jats:italic>\n = 0.034) are prone to develop orbital mucormycosis. On multivariate logistic regression analysis, these variables did not emerge as independent risk factors.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Patients with severe COVID-19 infection along with other associated risk factors can be prone to develop severe forms of mucormycosis. We did not find them to be statistically significant on multivariate analysis. In the future, large scale studies are needed to know their significance.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/joco.joco_78_22","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T18:38:30Z","timestamp":1717267110000},"page":"460-464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of Risk Factors among Nasal and Orbital Mucormycosis in Coronavirus Disease 2019 Infection"],"prefix":"10.4103","volume":"34","author":[{"given":"Ramasamy","family":"Vidhyadevi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Saudhamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Padmanaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devisundaram","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvetha","family":"Kannappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopalsamy","family":"Suryaprabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240910","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/cid\/cir864","article-title":"Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: Molecular mycologic perspectives","volume":"54","author":"Kwon-Chung","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R2-12-20240910","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/jof4020046","article-title":"Mucormycosis: Battle with the deadly enemy over a five-year period in India","volume":"4","author":"Chander","year":"2018","journal-title":"J Fungi (Basel"},{"key":"R3-12-20240910","first-page":"39","article-title":"Fungal sinusitis","volume":"316","author":"deShazo","year":"1998","journal-title":"Am J Med Sci"},{"key":"R4-12-20240910","first-page":"e10726","article-title":"Rhino-Orbital mucormycosis associated With COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"R5-12-20240910","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0002-9343(57)90023-2","article-title":"Fungus infections associated with antibiotic and steroid therapy","volume":"22","author":"Torack","year":"1957","journal-title":"Am J Med"},{"key":"R6-12-20240910","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R7-12-20240910","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India \u2013 Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R8-12-20240910","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fpubh.2016.00114","article-title":"Cadmium level, glycemic control, and indices of renal function in treated type II diabetics: Implications for polluted environments","volume":"4","author":"Anetor","year":"2016","journal-title":"Front Public Health"},{"key":"R9-12-20240910","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/qjmed\/hcab190","article-title":"COVID-19-associated mucormycosis presenting to the emergency department-an observational study of 70 patients","volume":"114","author":"Ramaswami","year":"2021","journal-title":"QJM"},{"key":"R10-12-20240910","doi-asserted-by":"crossref","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R11-12-20240910","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R12-12-20240910","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"key":"R13-12-20240910","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R14-12-20240910","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: An updated systematic review of literature","volume":"64","author":"Pal","year":"2021","journal-title":"Mycoses"},{"key":"R15-12-20240910","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/myc.12243","article-title":"Mucormycosis in India: Unique features","volume":"57","author":"Chakrabarti","year":"2014","journal-title":"Mycoses"},{"key":"R16-12-20240910","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/QCO.0b013e32834ab21e","article-title":"The emerging epidemiology of mould infections in developing countries","volume":"24","author":"Chakrabarti","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"R17-12-20240910","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.7326\/M21-2354","article-title":"The \u201cBlack Fungus\u201d in India: The emerging syndemic of COVID-19-associated mucormycosis","volume":"174","author":"Gandra","year":"2021","journal-title":"Ann Intern Med"},{"key":"R18-12-20240910","doi-asserted-by":"crossref","first-page":"102148","DOI":"10.1016\/j.tmaid.2021.102148","article-title":"COVID-19-associated mucormycosis: Case report and systematic review","volume":"44","author":"Dilek","year":"2021","journal-title":"Travel Med Infect Dis"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_78_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:50:00Z","timestamp":1787770200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_78_22"}},"subtitle":["A Cross-Sectional Study"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/joco.joco_78_22","relation":{},"ISSN":["2452-2325"],"issn-type":[{"value":"2452-2325","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}